HRTS

Exchange-traded product on NASDAQ (US)

Type
Exchange-traded product
Share class
—
Status
listed
ISIN
—
Currency
—
Represents the company
No

Holdings as of Aug 31, 2026

46 lines, 43 linked, weights sum to 99.92% · Actively managed (N-CEN)

Holding Ticker / identifier Type Shares Change Weight Market value
Eli Lilly & Co LLY US5324571083 Equity 5,343 −70 11.11% $ 6.18M
Thermo Fisher Scientific Inc TMO US8835561023 Equity 4,616 +431 5.12% $ 2.849M
UnitedHealth Group Inc UNH US91324P1021 Equity 7,195 +36 5.04% $ 2.802M
Novo Nordisk A/S NOVOB DK0062498333 Equity 58,624 −831 4.79% $ 2.664M
Merck & Co Inc MRK US58933Y1055 Equity 16,233 −2,439 4.31% $ 2.399M
Johnson & Johnson JNJ US4781601046 Equity 8,166 −108 3.90% $ 2.171M
Roche Holding AG
RHHBY US7711951043 Equity 38,978 −5,560 3.76% $ 2.093M
Revolution Medicines Inc RVMD US76155X1000 Equity 9,951 −1,020 3.68% $ 2.046M
Cytokinetics Inc CYTK US23282W6057 Equity 27,649 +10,580 3.53% $ 1.961M
Bridgebio Pharma Inc BBIO US10806X1028 Equity 23,113 +2,786 3.18% $ 1.77M
Gilead Sciences Inc GILD US3755581036 Equity 11,884 −1,377 3.13% $ 1.739M
Abbott Laboratories ABT US0028241000 Equity 15,601 −208 3.10% $ 1.722M
Vertex Pharmaceuticals Inc VRTX US92532F1003 Equity 3,079 −319 3.02% $ 1.677M
Danaher Corp DHR US2358511028 Equity 7,756 +199 2.98% $ 1.656M
AstraZeneca PLC AZN GB0009895292 Equity 9,969 −1,209 2.91% $ 1.617M
Novartis AG
NOVN CH0012005267 Equity 10,564 −1,063 2.90% $ 1.611M
AbbVie Inc ABBV US00287Y1091 Equity 5,088 −626 2.35% $ 1.305M
Bristol-Myers Squibb Co BMY US1101221083 Equity 18,719 −220 2.25% $ 1.251M
Kodiak Sciences Inc KOD US50015M1099 Equity 33,234 new +33,234 2.23% $ 1.241M
Intuitive Surgical Inc ISRG US46120E6023 Equity 3,200 +1,610 2.17% $ 1.206M
Medtronic PLC MDT IE00BTN1Y115 Equity 13,029 −174 2.12% $ 1.181M
McKesson Corp MCK US58155Q1031 Equity 1,182 −14 1.88% $ 1.046M
Dexcom Inc DXCM US2521311074 Equity 11,085 −2,427 1.82% $ 1.009M
Amgen Inc AMGN US0311621009 Equity 1,901 −1,045 1.47% $ 817.202K
Madrigal Pharmaceuticals Inc MDGL US5588681057 Equity 1,499 −20 1.46% $ 809.505K
Edwards Lifesciences Corp EW US28176E1082 Equity 8,572 −1,916 1.40% $ 777.909K
Regeneron Pharmaceuticals Inc REGN US75886F1075 Equity 929 −479 1.34% $ 742.345K
Stryker Corp SYK US8636671013 Equity 2,284 new +2,284 1.33% $ 739.559K
Boston Scientific Corp BSX US1011371077 Equity 15,214 −71 1.32% $ 734.836K
Alnylam Pharmaceuticals Inc ALNY US02043Q1076 Equity 2,566 +612 1.11% $ 617.611K
Teva Pharmaceutical Industries TEVA US8816242098 Equity 16,554 −13,719 1.07% $ 596.772K
Chugai Pharmaceutical Co Ltd 4519 JP3519400000 Equity 13,731 −184 1.07% $ 594.193K
Xenon Pharmaceuticals Inc XENE CA98420N1050 Equity 8,283 −110 0.90% $ 498.802K
Arrowhead Pharmaceuticals Inc ARWR US04280A1007 Equity 5,263 −1,977 0.78% $ 433.619K
Scholar Rock Holding Corp SRRK US80706P1030 Equity 6,177 −3,470 0.63% $ 350.854K
Stoke Therapeutics Inc STOK US86150R1077 Equity 9,917 −132 0.56% $ 309.41K
MBX Biosciences Inc MBX US55287L1017 Equity 5,010 −3,751 0.56% $ 308.616K
Viking Therapeutics Inc VKTX US92686J1060 Equity 8,426 −112 0.50% $ 276.204K
Insulet Corp PODD US45784P1012 Equity 1,827 −1,008 0.49% $ 271.602K
Gubra A/S GUBRA DK0062266474 Equity 4,429 −58 0.47% $ 261.11K
Insmed Inc INSM US4576693075 Equity 2,038 −1,411 0.45% $ 248.269K
Zealand Pharma A/S ZEAL DK0060257814 Equity 5,223 −70 0.44% $ 243.479K
Kailera Therapeutics Inc KLRA US4829311020 Equity 14,039 new +14,039 0.39% $ 216.201K
First American Treasury Obliga
FXFXX US31846V3289 Money market 195,957.05 −177,539.65 0.35% $ 195.957K
Intellia Therapeutics Inc NTLA US45826J1051 Equity 13,708 −184 0.31% $ 174.503K
Ionis Pharmaceuticals Inc IONS US4622221004 Equity 2,427 −3,172 0.26% $ 146.494K